Related Experiment Video
Updated: Jun 30, 2026
06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Rapid Progressive Liver Atrophy During Immune Checkpoint Inhibitor Hepatitis: Imaging Perspectives Beyond
Chukwuka Elendu1, Adetokunbo A Adesina2, Olisa S Okabekwa3
1Federal University Teaching Hospital Owerri Nigeria.
Clinical Case Reports
|June 29, 2026
Summary
Immune checkpoint inhibitor-associated hepatitis can worsen even with mild liver enzyme increases, especially in cirrhosis patients. Early recognition of unusual symptoms and combined assessments are key for managing liver injury.
Area of Science:
- Hepatology
- Immunology
- Oncology
Background:
- Immune checkpoint inhibitors (ICIs) are crucial cancer therapies.
- ICI-associated hepatitis is a known side effect.
- Cirrhosis complicates ICI-related liver injury management.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):